Corrigendum to “Comprehensive in-silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small molecular inhibitors for the treatment of Cholangiocarcinoma” [Comput. Biol. Med. 166 (2023) 107572]

Manju Nidagodu Jayakumar, Jibran Sualeh Muhammad*, Mainak Dutta*, Sainitin Donakonda*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that in the initial publication of this study, typographical errors were identified in Figs. 1 and 2. In Fig. 1D, pie chart the number of non-upregulated genes has to be corrected to 202, and the corresponding percentage has to be adjusted to “91.82 %". Similarly, in Result Section 3.3, the total count of chaperones was mistyped as 200, it should be corrected to 220, in lines 4 and 8. The Venn diagram's Fig. 2B had 144 incorrectly labelled; it must be corrected to 114. The authors would like to apologise for any inconvenience caused.[Formula

Original languageEnglish
Article number107756
Number of pages3
JournalComputers in Biology and Medicine
Volume168
Early online date1 Dec 2023
DOIs
Publication statusPublished - Jan 2024

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Ltd

ASJC Scopus subject areas

  • Health Informatics
  • Computer Science Applications

Fingerprint

Dive into the research topics of 'Corrigendum to “Comprehensive in-silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small molecular inhibitors for the treatment of Cholangiocarcinoma” [Comput. Biol. Med. 166 (2023) 107572]'. Together they form a unique fingerprint.

Cite this